
Akumin AKU
Quarterly report 2023-Q3
added 12-12-2023
Akumin Cash and Cash Equivalents 2011-2026 | AKU
Annual Cash and Cash Equivalents Akumin
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 59.4 M | 48.4 M | 44.4 M | 23.4 M | 19.3 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 59.4 M | 19.3 M | 39 M |
Quarterly Cash and Cash Equivalents Akumin
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.6 M | 38 M | 45.4 M | 59.4 M | 59.4 M | 38.4 M | 40.2 M | 48.4 M | 55.9 M | 74.4 M | 123 M | 44.4 M | 27.4 M | - | - | 23.4 M | - | - | - | 19.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 123 M | 19.3 M | 48.6 M |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
11.9 M | $ 1.32 | -19.02 % | $ 1.76 M | ||
|
Agilent Technologies
A
|
1.48 B | $ 112.31 | -0.84 % | $ 34.1 B | ||
|
Castle Biosciences
CSTL
|
117 M | $ 19.54 | 3.5 % | $ 566 M | ||
|
Fulgent Genetics
FLGT
|
55.1 M | $ 15.85 | -2.1 % | $ 479 M | ||
|
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
1.13 B | $ 140.5 | -1.91 % | $ 22.3 B | ||
|
Interpace Biosciences
IDXG
|
2.5 M | $ 1.8 | - | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
65.4 M | $ 19.85 | -3.12 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
2 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
359 M | $ 94.39 | -2.36 % | $ 6.37 B | ||
|
Medpace Holdings
MEDP
|
497 M | $ 419.67 | 0.12 % | $ 12.1 B | ||
|
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
66.9 M | $ 1 053.18 | 1.08 % | $ 21.7 B | ||
|
Myriad Genetics
MYGN
|
150 M | $ 3.63 | 0.14 % | $ 336 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | ||
|
NeoGenomics
NEO
|
160 M | $ 8.28 | -0.96 % | $ 1.06 B | ||
|
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
4.14 M | $ 18.68 | -1.29 % | $ 418 M | ||
|
Natera
NTRA
|
466 M | $ 187.81 | -4.62 % | $ 18.5 B | ||
|
Charles River Laboratories International
CRL
|
214 M | $ 155.3 | -2.4 % | $ 7.7 B | ||
|
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | ||
|
Koninklijke Philips N.V.
PHG
|
2.79 B | $ 25.3 | -0.82 % | $ 24 B | ||
|
Guardant Health
GH
|
378 M | $ 93.62 | -5.11 % | $ 11.7 B | ||
|
Personalis
PSNL
|
124 M | $ 6.53 | -2.68 % | $ 583 M | ||
|
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | ||
|
Senseonics Holdings
SENS
|
40.2 M | $ 5.74 | -1.37 % | $ 240 M | ||
|
ICON Public Limited Company
ICLR
|
752 M | $ 117.02 | -0.06 % | $ 9.65 B | ||
|
Soleno Therapeutics
SLNO
|
70.1 M | $ 52.99 | - | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
2.4 M | $ 2.33 | -3.32 % | $ 5.35 M | ||
|
Laboratory Corporation of America Holdings
LH
|
532 M | $ 251.91 | -0.83 % | $ 21 B | ||
|
Thermo Fisher Scientific
TMO
|
9.85 B | $ 441.56 | -1.47 % | $ 166 B | ||
|
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.56 | -3.84 % | $ 201 M | ||
|
Celcuity
CELC
|
166 M | $ 135.89 | 0.86 % | $ 6.35 B | ||
|
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
183 M | $ 49.5 | -6.52 % | $ 2.96 B | ||
|
Neogen Corporation
NEOG
|
129 M | $ 8.28 | -1.84 % | $ 1.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
420 M | $ 187.84 | -0.05 % | $ 20.9 B | ||
|
Invitae Corporation
NVTA
|
257 M | - | - | $ 21.2 M |